Overview
Precision Instruments

ASAHI INTECC CO.,LTD.

Asahi Intecc is a research and development-oriented medical device manufacturer specializing in minimally invasive treatment products, primarily guidewires and catheter products used in endovascular procedures across cardiovascular, peripheral, abdominal, and cerebrovascular applications. The company markets its own branded products globally while also providing OEM/ODM manufacturing services and supplying medical and industrial components to third-party manufacturers. Its core proprietary technologies—wire drawing, wire forming, coating, and torque transmission—enable the development of ultra-fine, high-precision wire-based products that serve both medical and industrial markets.

Market Cap
¥981B
US$6.26B
EV
¥903B
US$5.76B
Stock¥3,698▼-1.26%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
16.7
x
LTM EV/EBIT
19.9
x
LTM PER
30.6
x
LTM PBR
5.7
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▲+29.1%pt
1001234
Oct 24, 25 – Oct 23, 26StockTOPIX
1Feb 16, 26Q2 earnings: revenue +15.9%, op. profit +40.1%, guidance raised
2Feb 24, 26Continued rally on Q2: revenue +15.9%, op. profit +40.1% beat
3Feb 27, 26Sustained re-rating on Q2 op. profit +40.1% and raised guidance
4Aug 17, 26Full-year FY2026/06 earnings announced
MC → EV Bridge
981BUS$6.26BMarket Cap9.13BUS$58.2M+ Debt64.3BUS$410M− Cash24.3BUS$155M− Inv. Sec.0.95BUS$6.07M+ NCI903BUS$5.76BEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
77.7US$496M'22/690.1US$575M'23/6108US$686M'24/6120US$765M'25/6145US$927M'26/6
EBITDA 5Y (¥B)
21.7US$138M'22/625.5US$163M'23/630.6US$195M'24/639.3US$250M'25/654.0US$344M'26/6
Net Income 5Y (¥B)
10.9US$69.2M'22/613.1US$83.6M'23/615.8US$101M'24/612.7US$81.2M'25/632.1US$205M'26/6
Capital Structure
95%
EquityD/E 0.05xDebt
Liquidity vs Debt 5Y (¥B)▲ Net Cash
CashInv. Sec.Debt
39.4US$251M12.2US$77.7M'22/641.1US$262M14.3US$90.9M'23/650.8US$324M8.20US$52.3M'24/673.6US$469M11.1US$70.8M'25/688.5US$565M9.13US$58.2M'26/6
Shareholders
Top 10 hold 47.6%
1
The Master Trust Bank of Japan, Ltd. (Trust Account)
14.15%
2
Custody Bank of Japan, Ltd. (Trust Account)
8.70%
3
Bowen Holdings Co., Ltd.
8.70%
4
THE CHASE MANHATTAN BANK, N.A. LONDON (Standing Proxy: Mizuho Bank, Ltd.)
2.93%
5
ICSP Co., Ltd.
2.71%
6
STATE STREET BANK AND TRUST COMPANY 505001 (Standing Proxy: Mizuho Bank, Ltd.)
2.56%
7
Masahiko MIYATA
2.19%
8
THE BANK OF NEW YORK MELLON 140044 (Standing Proxy: Mizuho Bank, Ltd.)
1.92%
9
Kenji MIYATA
1.91%
10
STATE STREET BANK AND TRUST COMPANY 505103 (Standing Proxy: Mizuho Bank, Ltd.)
1.85%
Management
12 officers
Masahiko MIYATA
Representative Director, Chairman
Apr 1992 Joined NTT Data Communications Corporation Nov 1994 Joined the Company; General Manager, Planning Office, General Headquarters Dec 1995 Director of the Company; General Manager, Corporate Planning Department Mar 1999 Managing Director; Assistant to General Manager, Medical Business Division; General Manager, Production Technology Department Jul 2000 General Manager, Medical Business Division Sep 2001 Senior Managing Director Sep 2003 Director, ASAHI INTECC THAILAND CO., LTD. (current) Mar 2004 Deputy President (Representative Director) of the Company Mar 2006 President (Representative Director), Compass Med Integration Co., Ltd. (now Asahi Intecc J Sales Co., Ltd.) Aug 2006 Director, ASAHI INTECC HANOI CO., LTD. (current) Jun 2007 CEO, ASAHI INTECC THAILAND CO., LTD. Sep 2009 President & CEO (Representative Director) of the Company Sep 2009 President (Representative Director), Filmecc Co., Ltd. Jul 2016 Director, Filmecc Co., Ltd. Apr 2023 President (Representative Director), Magnea Co., Ltd. (current) Sep 2024 Chairman of the Board of the Company Jun 2025 Chairman, Japan Medical Device Technology Association (current); Vice Chairman, Japan Medical Device Industry Federation (current) Sep 2025 Director, Asahi Intecc J Sales Co., Ltd. (current) Jul 2026 Representative Director, Chairman of the Company (current); Representative Director, Chairman, Asahi Surgical Robotics Co., Ltd. (current); Chairman, ASAHI INTECC USA, INC. (current); Chairman, Filmecc USA, INC. (current)
1967-03-15
Kenji MIYATA
Representative Director, President, CEO
Apr 1993 Joined the Company Jan 1997 Deputy President, ASAHI INTECC THAILAND CO., LTD. Jul 1997 Director of the Company Jun 1999 General Manager, Production Control Division, Industrial Equipment Business Division Jul 2000 Executive Officer; General Manager, Business Administration Office, Industrial Equipment Business Division Jul 2001 General Manager, Medical Device Department, Device Business Division Aug 2002 Deputy General Manager, Device Business Division; General Manager, Quality Assurance Department Sep 2003 Director of the Company Oct 2004 Director, ASAHI INTECC THAILAND CO., LTD. Jul 2006 General Manager, Device Business Division Jul 2009 Director, Zeema Co., Ltd. Jul 2010 General Manager, Kaizen Promotion Office Sep 2010 Managing Director of the Company Jul 2011 President (Representative Director), Asahi Intecc Zeema Co., Ltd. Jul 2013 General Manager, Technology Improvement Office Sep 2013 President (Representative Director), Toyoflex Co., Ltd. Sep 2013 President & CEO, TOYOFLEX CEBU CORPORATION Jan 2015 Director, ASAHI INTECC THAILAND CO., LTD. (current) Jan 2015 Director, ASAHI INTECC HANOI CO., LTD. Jul 2015 President, ASAHI INTECC HANOI CO., LTD. Sep 2015 Director, Deputy President of the Company Jul 2016 General Manager, Quality Assurance Headquarters; Chairman, ASAHI INTECC HANOI CO., LTD. (current) Sep 2016 Deputy President (Representative Director) of the Company Jul 2017 Director, TOYOFLEX CEBU CORPORATION (current) Jul 2018 Director, Ficus Co., Ltd. Jul 2020 General Manager, Device Business Headquarters May 2022 Director, walkey Co., Ltd. (current) Sep 2022 Director, Filmecc Co., Ltd.; Director, Nihon Chemical Coat Co., Ltd. Jan 2023 President (Representative Director), Lake R&D Co., Ltd. Jul 2024 General Manager, Production Headquarters Sep 2024 President & CEO (Representative Director) of the Company (current)
1970-07-16
Makoto NISHIUCHI
Managing Director, General Manager, Medical Business Headquarters, Head of Brand Business Unit, and Chief Digital Officer (CDO)
Apr 1990 Joined Mitsubishi Heavy Industries, Ltd. Oct 2005 Joined the Company Jul 2008 Deputy Group Manager, R&D Group, Medical Business Division May 2010 Group Manager, R&D Group, Medical Business Division Jul 2015 Executive Officer Jul 2016 Director, ASAHI INTECC USA, INC. (current) Jan 2017 Head of R&D, Medical Business Division Oct 2017 Senior Executive Officer Jul 2018 Director, RetroVascular, Inc. (now ASAHI Medical Technologies, Inc.) (current) Sep 2018 Director of the Company Jul 2019 General Manager, Brand Business Unit, Medical Business Division (current) Jul 2022 Chief Digital Officer (current) Jul 2024 Deputy General Manager, Medical Business Headquarters Sep 2024 Managing Director of the Company (current); General Manager, Medical Business Headquarters (current)
1964-08-15
Yoshinori TERAI
Director, General Manager, New Business Development Division
Mar 1998 Joined Yamaha Corporation Oct 1998 Joined the Company; Assistant Manager, R&D Department, Medical Business Division Jan 2000 Assistant Manager, Medical Business Division (attached) Jul 2000 Head of U.S. Office, Medical Business Division Jul 2004 President & CEO, ASAHI INTECC USA, INC. Nov 2006 Director, RetroVascular, Inc. (now ASAHI Medical Technologies, Inc.) Sep 2008 Executive Officer; in charge of overseas business Jul 2009 General Manager, Overseas Sales, Medical Business Division Jan 2010 General Manager, Marketing, Medical Business Division Apr 2012 Director, Asahi Yingda Kexue Mao (Beijing) Co., Ltd. Sep 2013 Director of the Company (current) Jul 2014 General Manager, Sales & Marketing, Medical Business Division Mar 2016 General Manager, Global Business Development Office, Medical Business Division Jul 2016 Director, Asahi Intecc J Sales Co., Ltd. Jul 2019 General Manager, New Business Development Division (current) Jul 2019 General Manager, Sales & Marketing, Brand Business Unit, Medical Business Division Feb 2020 Director, ASAHI INTECC CIS LLC; Director, ASAHI INTECC EUROPE B.V. (current) Jul 2020 General Manager, Overseas Sales & Marketing, Brand Business Unit, Medical Business Division; Director, ASAHI INTECC Deutschland GmbH (current) Jun 2021 President & CEO, Filmecc USA, Inc. (current) Jul 2021 President & CEO, Pathways Medical Corporation (current); Director, Rev.1 Engineering, Inc. (current) Apr 2023 Director, Magnea Co., Ltd. (current) Dec 2023 President & CEO, Asahi Medical Technologies, Inc. (current) Jul 2026 Director, ASAHI INTECC USA, INC. (current)
1963-09-13
Mizuho ITO
Director, CFO, General Manager, Administration Division, and Head of Business Strategy Office
Mar 1996 Joined Tohmatsu & Co. (now Deloitte Touche Tohmatsu LLC) May 2003 Joined the Company May 2005 Deputy General Manager, Business Strategy Office Apr 2008 Audit & Supervisory Board Member, ASAHI INTECC HANOI CO., LTD. Sep 2008 General Manager, Business Strategy Office (current) Sep 2009 Audit & Supervisory Board Member, Zeema Co., Ltd. Oct 2010 Audit & Supervisory Board Member, Filmecc Co., Ltd. Apr 2012 Supervisor, Asahi Yingda Kexue Mao (Beijing) Co., Ltd. (current) Sep 2013 Director, Toyoflex Co., Ltd. Dec 2013 Manager, Accounting Group, Administration Division Jul 2015 Executive Officer Jul 2016 General Manager, Administration Division (current); Audit & Supervisory Board Member, Asahi Intecc J Sales Co., Ltd. (current) Sep 2016 Director, CFO of the Company (current) Jul 2018 Director, RetroVascular, Inc. (now ASAHI Medical Technologies, Inc.) Jul 2021 Director, A-Traction Inc. (now Asahi Surgical Robotics Co., Ltd.) (current) Apr 2023 Director, Magnea Co., Ltd. (current) Apr 2025 Supervisor, Asahi Yingda Medical Instruments (Nanning) Co., Ltd. (current)
1973-09-08
Kazuto ISHIHARA
Director, Deputy General Manager, Medical Business Headquarters, and Head of R&D
Feb 1984 Joined Terumo Corporation Feb 2018 Joined the Company; Head of R&D, Medical Business Division Sep 2018 Executive Officer Jul 2019 Deputy Head of R&D, Brand Business Unit, Medical Business Division Sep 2019 Head of Clinical Development Office, Medical Business Division Jul 2024 Deputy General Manager, Fundamental Technology R&D Headquarters Sep 2024 Director of the Company (current) Jul 2026 Deputy General Manager, Medical Business Headquarters (current); Head of R&D, Brand Business Unit, Medical Business Headquarters (current)
1961-06-24
Shinjiro OTANI
Director, General Manager, Human Resources Development Division
Apr 1998 Joined TYK Corporation Nov 2002 Joined the Company Jul 2016 Director, Toyoflex Co., Ltd. Jul 2021 General Manager, President's Office May 2022 Audit & Supervisory Board Member, walkey Co., Ltd. (current) Jul 2023 General Manager, Human Resources Development Group (current) Oct 2023 Executive Officer Sep 2024 President (Representative Director), Lake R&D Co., Ltd.; Director, Ficus Co., Ltd. (current) Jan 2025 Director, Nitta Mold Co., Ltd. Sep 2025 Director of the Company (current); Director, Lake R&D Co., Ltd. (current) Oct 2025 General Manager, Human Resources Development Division (current)
1975-09-09
Takahiro KUSAKARI
Director
Jul 2007 Joined SBI Real Marketing Co., Ltd. Oct 2008 Joined Sawakami Asset Management Co., Ltd. Nov 2010 Fund Manager, Sawakami Asset Management Co., Ltd. Jan 2013 Chief Investment Officer, Sawakami Asset Management Co., Ltd. Jun 2015 Director and Chief Investment Officer, Sawakami Asset Management Co., Ltd. Jul 2022 Joined Sawakami Holdings Co., Ltd. Sep 2022 Outside Director of the Company (current) Mar 2023 Joined Catalyst Investment Advisors Co., Ltd. Jun 2023 Director and Co-President, Catalyst Investment Advisors Co., Ltd. Apr 2026 Executive Officer and General Manager, Equity Investment Department, Monex Asset Management Co., Ltd. (current)
1979-03-14
Masahiro TAGUCHI
Director
Apr 1980 Joined Olympus Optical Co., Ltd. (now Olympus Corporation) Jun 2010 Executive Officer, Olympus Corporation Apr 2012 Managing Executive Officer, Olympus Corporation; President & CEO (Representative Director), Olympus Medical Systems Corp. Apr 2013 Outside Director, Sony Olympus Medical Solutions Inc. Apr 2015 General Manager, Sales & Marketing Division and Head of Medical Business, Olympus Corporation Jun 2015 Director and Managing Executive Officer, Olympus Corporation Apr 2019 Executive Officer and COO, Olympus Corporation Apr 2020 Executive Officer and CTO, Olympus Corporation Aug 2022 Outside Director, Sacho Denki Co., Ltd. Sep 2023 Outside Director of the Company (current) Apr 2026 Outside Director, MIRAINI Holdings Co., Ltd. (current)
1958-01-26
Takashi TOMITA
Director, Audit and Supervisory Committee Member
Oct 2001 Registered with Nagoya Bar Association (now Aichi Bar Association); joined Higashizakura Sogo Law Office Apr 2006 Part-time Lecturer, Faculty of Law, Nagoya Keizai University Dec 2006 Legal Advisor, City of Nagoya (current) Oct 2007 Opened Tomita & Yamauchi Law Office (now Yomei Law Office) Apr 2010 Staff Member, Research Office, Aichi Bar Association Apr 2011 Part-time Lecturer, Aichi University Law School May 2011 Member, Committee on Bar Association Inquiry System, Japan Federation of Bar Associations (current) Apr 2013 Member, Kasugai City Information Disclosure and Personal Information Protection Review Board Apr 2016 Vice President, Aichi Bar Association Sep 2016 Substitute Audit and Supervisory Committee Member of the Company Sep 2018 Outside Director (Audit and Supervisory Committee Member) of the Company (current) Apr 2020 Head of Bar Association Inquiry Research Office, Aichi Bar Association Dec 2021 Public Interest Member, Aichi Labor Relations Commission (current) Jun 2024 Member, Aichi Expropriation Commission (current) Dec 2025 Chairman, Aichi Labor Relations Commission (current)
1975-04-03
Reiko FUKAYA
Director, Audit and Supervisory Committee Member
Oct 1999 Joined Chuo Audit Corporation Apr 2003 Registered as Certified Public Accountant Aug 2007 Joined Azusa Audit Corporation (now Azusa Audit LLC) Apr 2011 Opened Reiko Fukaya CPA Office Jun 2016 Secretary, Tokai Chapter, Japanese Institute of Certified Public Accountants Mar 2017 Registered as Certified Tax Accountant Jun 2019 Chair, Public Relations Committee, Tokai Chapter, Japanese Institute of Certified Public Accountants Sep 2020 Substitute Audit and Supervisory Committee Member of the Company Sep 2022 Outside Director (Audit and Supervisory Committee Member) of the Company (current) Apr 2023 Audit & Supervisory Board Member, Sugiyama Jogakuen Educational Corporation (current) Jul 2023 Part-time Research Fellow, Kyoto University Graduate School of Management Jun 2026 Outside Director (Audit and Supervisory Committee Member), Aica Kogyo Co., Ltd. (current)
1973-05-12
Shigeki MORIGUCHI
Director, Audit and Supervisory Committee Member
Apr 1981 Joined Tokai Bank, Ltd. (now MUFG Bank, Ltd.) Mar 2001 Deputy Manager, Administrative Planning Department, UFJ Holdings, Inc. (now Mitsubishi UFJ Financial Group, Inc.) Nov 2006 Executive Officer and General Manager, Administration & Personnel Department, The Bank of Tokyo-Mitsubishi UFJ, Ltd. (now MUFG Bank, Ltd.) Apr 2009 Executive Officer and Branch Manager, Shin-Nagoya Ekimae Branch, MUFG Bank, Ltd. Jun 2011 Managing Executive Officer, Mitsubishi UFJ Research & Consulting Co., Ltd. Apr 2019 Managing Director, Aichi Credit Guarantee Association Jun 2021 Part-time Audit & Supervisory Board Member, Hosho Kyokai Saiken Kaishu Co., Ltd. Apr 2022 Senior Adviser, Aichi Credit Guarantee Association Sep 2022 Substitute Audit and Supervisory Committee Member of the Company Sep 2024 Outside Director (Audit and Supervisory Committee Member) of the Company (current)
1957-07-23
Large Shareholding Reports
Amova Asset Management Co., Ltd.
2026-09-04
3.14%
BlackRock Japan Co., Ltd.
2026-03-18
1.55%
Capital Research and Management Company
2026-02-20
4.43%→2.96%
Goldman Sachs Asset Management Co., Ltd.
2025-10-07
1.93%→1.58%
Disclosures
No disclosures
Primary Source Filings
EDINET
2026-09-28
Annual Securities Report
Period: Jul 2025 – Jun 2026
EDINET
2026-09-04
Large Shareholding Report
TDnet
2026-08-14
Full-Year Earnings Flash
FY ending Jun 2026
TDnet
2026-05-15
Q3 Earnings Flash
FY ending Jun 2026
EDINET
2026-03-18
Large Shareholding Report
EDINET
2026-02-20
Large Shareholding Report
EDINET
2026-02-13
Semi-Annual Securities Report
Period: Jul 2025 – Jun 2026
TDnet
2025-11-14
Q1 Earnings Flash
FY ending Jun 2026
EDINET
2025-10-07
Large Shareholding Report
EDINET
2025-09-24
Annual Securities Report
Period: Jul 2024 – Jun 2025
TDnet
2025-05-15
Q3 Earnings Flash
FY ending Jun 2025
EDINET
2025-02-14
Semi-Annual Securities Report
Period: Jul 2024 – Jun 2025
TDnet
2024-11-14
Q1 Earnings Flash
FY ending Jun 2025
EDINET
2024-09-27
Annual Securities Report
Period: Jul 2023 – Jun 2024
EDINET
2024-05-15
Quarterly Securities Report
Period: Jan 2024 – Mar 2024
EDINET
2024-02-14
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-14
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-09-29
Annual Securities Report
Period: Jul 2022 – Jun 2023
EDINET
2023-05-15
Quarterly Securities Report
Period: Jan 2023 – Mar 2023
EDINET
2023-02-14
Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINET
2022-11-11
Quarterly Securities Report
EDINET
2022-09-30
Annual Securities Report
EDINET
2022-05-13
Quarterly Securities Report
EDINET
2022-02-14
Quarterly Securities Report
EDINET
2021-11-12
Quarterly Securities Report
EDINET
2021-09-30
Annual Securities Report
EDINET
2021-05-14
Quarterly Securities Report
EDINET
2021-02-12
Quarterly Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →